Skip to main content
. 2010 Oct 5;10:527. doi: 10.1186/1471-2407-10-527

Table 2.

Treatment Response According to Subtypes (n = 105 patients with measurable diseases)

Total (n = 105) HR (n = 68) HER2 (n = 14) TN (n = 23) p
Median cycles
6.0 (1-12)
5.9 (1-12)
4.8 (1-9)
5.6 (1-9)
0.454
Response
CR
2
2
0
0

PR
55
36
6
13

SD
25
19
3
4

PD
20
11
4
5

Not evaluable
2
0
1
1

Overall response rate 57 (54.3%) 38 (55.9%) 6 (42.9%) 13 (56.5%) 0.542

CR; complete response, PR; partial response, SD; stable disease, PD; progressive disease